Synthetic Polymers

Principles of Regenerative Medicine

Volumn , Issue , 2011, Pages 587-622

  Hacker, M C ^a   Mikos, A G ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Rice University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882563043     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381422-7.10033-1     Document Type: Chapter

References (247)

1. Agrawal C.M., Athanasiou K.A., Heckman J.D. Biodegradable PLA-PGA polymers for tissue engineering in orthopaedics. Mater. Sci. Forum 2000, 1997:115-128.
2. Albertsson A.C., Varma I.K. Recent developments in ring opening polymerization of lactones for biomedical applications. Biomacromolecules 2003, 4:1466-1486.
3. Allcock H.R., Kwon S. Ionically cross-linkable polyphosphazene: poly[bis(carboxylatophenoxy)phosphazene] and its hydrogels and membranes. Macromolecules 1989, 22:75-79.
4. Amecke B., Bendix D., Entenmann G. Resorbable polyesters: composition, properties, applications. Clin. Mater. 1992, 10:47-50.
5. An Y., Hubbell J.A. Intraarterial protein delivery via intimally-adherent bilayer hydrogels. J. Control. Release 2000, 64:205-215.
6. Anderson J.M., Shive M.S. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev. 1997, 28:5-24.
7. Andriano K.P., Tabata Y., Ikada Y., Heller J. In vitro and in vivo comparison of bulk and surface hydrolysis in absorbable polymer scaffolds for tissue engineering. J. Biomed. Mater. Res. 1999, 48:602-612.
8. Andrianov A.K., Payne L.G. Protein release from polyphosphazene matrices. Adv. Drug Deliv. Rev. 1998, 31:185-196.
9. Anseth K.S., Shastri V.R., Langer R. Photopolymerizable degradable polyanhydrides with osteocompatibility. Nat. Biotechnol. 1999, 17:156-159.
10. Arepalli S.R., Bezabeh S., Brown S.L. Allergic reaction to platinum in silicone breast implants. J. Long Term Eff. Med. Implants 2002, 12:299-306.
11. Athanasiou K.A., Niederauer G.G., Agrawal C.M. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 1996, 17:93-102.
12. Bazile D., Prud'homme C., Bassoullet M.T., Marlard M., Spenlehauer G., Veillard M. Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J. Pharm. Sci. 1995, 84:493-498.
13. Behravesh E., Yasko A.W., Engel P.S., Mikos A.G. Synthetic biodegradable polymers for orthopaedic applications. Clin. Orthop. Relat. Res., 1999, S118-S129.
14. Behravesh E., Shung A.K., Jo S., Mikos A.G. Synthesis and characterization of triblock copolymers of methoxy poly(ethylene glycol) and poly(propylene fumarate). Biomacromolecules 2002, 3:153-158.
15. Behravesh E., Timmer M.D., Lemoine J.J., Liebschner M.A.K., Mikos A.G. Evaluation of the in vitro degradation of macroporous hydrogels using gravimetry, confined compression testing, and microcomputed tomography. Biomacromolecules 2002, 3:1263-1270.
16. Behravesh E., Zygourakis K., Mikos A.G. Adhesion and migration of marrow-derived osteoblasts on injectable in situ crosslinkable poly(propylene fumarate-co-ethylene glycol)-based hydrogels with a covalently linked RGDS peptide. J. Biomed. Mater. Res. A 2003, 65:260-270.
17. Beniash E., Hartgerink J.D., Storrie H., Stendahl J.C., Stupp S.I. Self-assembling peptide amphiphile nanofiber matrices for cell entrapment. Acta Biomater. 2005, 1:387-397.
18. Betre H., Setton L.A., Meyer D.E., Chilkoti A. Characterization of a genetically engineered elastin-like polypeptide for cartilaginous tissue repair. Biomacromolecules 2002, 3:910-916.
19. Betz M.W., Modi P.C., Caccamese J.F., Coletti D.P., Sauk J.J., Fisher J.P. Cyclic acetal hydrogel system for bone marrow stromal cell encapsulation and osteodifferentiation. J. Biomed. Mater. Res. A 2008, 86:662-670.
20. Bobyn J.D., Mortimer E.S., Glassman A.H., Engh C.A., Miller J.E., Brooks C.E. Producing and avoiding stress shielding: laboratory and clinical observations of noncemented total hip arthroplasty. Clin. Orthop. Relat. Res., 1992, 79-96.
21. Boretos J.W., Pierce W.S. Segmented polyurethane: a new elastomer for biomedical applications. Science 1967, 158:1481-1482.
22. Bostman O., Pihlajamaki H. Clinical biocompatibility of biodegradable orthopaedic implants for internal fixation: a review. Biomaterials 2000, 21:2615-2621.
23. Bouillot P., Petit A., Dellacherie E. Protein encapsulation in biodegradable amphiphilic microspheres. I. Polymer synthesis and characterization and microsphere elaboration. J. Appl. Polym. Sci. 1998, 68:1695-1702.
24. Bourke S.L., Kohn J. Polymers derived from the amino acid tyrosine: polycarbonates, polyarylates and copolymers with poly(ethylene glycol). Adv. Drug Deliv. Rev. 2003, 55:447-466.
25. Brandl F., Henke M., Rothschenk S., Gschwind R., Breunig M., Blunk T., et al. Poly(ethylene glycol)-based hydrogels for intraocular applications. Adv. Eng. Mater. 2007, 9:1141-1149.
26. Brannon-Peppas L. Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery. Int. J. Pharm. 1995, 116:1-9.
27. Braunecker W.A., Matyjaszewski K. Controlled/living radical polymerization: features, developments, and perspectives. Progr. Polymer Sci. 2007, 32:93-146.
28. Brocchini S. Combinatorial chemistry and biomedical polymer development. Adv. Drug Deliv. Rev. 2001, 53:123-130.
29. Brook M.A. Platinum in silicone breast implants. Biomaterials 2006, 27:3274-3286.
30. Brunner A., Mader K., Gopferich A. pH and osmotic pressure inside biodegradable microspheres during erosion. Pharm. Res. 1999, 16:847-853.
31. Bryers J.D., Jarvis R.A., Lebo J., Prudencio A., Kyriakides T.R., Uhrich K. Biodegradation of poly(anhydride-esters) into non-steroidal anti-inflammatory drugs and their effect on Pseudomonas aeruginosa biofilms in vitro and on the foreign-body response in vivo. Biomaterials 2006, 27:5039-5048.
32. Burdick J.A., Anseth K.S. Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering. Biomaterials 2002, 23:4315-4323.
33. Burdick J.A., Philpott L.M., Anseth K.S. Synthesis and characterization of tetrafunctional lactic acid oligomers: a potential in situ forming degradable orthopaedic biomaterial. J. Polym. Sci. A 2001, 39:683-692.
34. Burdick J.A., Frankel D., Dernell W.S., Anseth K.S. An initial investigation of photocurable three-dimensional lactic acid-based scaffolds in a critical-sized cranial defect. Biomaterials 2003, 24:1613-1620.
35. Burkersroda F.V., Schedl L., Gopferich A. Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials 2002, 23:4221-4231.
36. Byrne M.E., Park K., Peppas N.A. Molecular imprinting within hydrogels. Adv. Drug Deliv. Rev. 2002, 54:149-161.
37. Cannizzaro S.M., Padera R.F., Langer R., Rogers R.A., Black F.E., Davies M.C., et al. A novel biotinylated degradable polymer for cell-interactive applications. Biotechnol. Bioeng. 1998, 58:529-535.
38. Cerrai P., Guerra G.D., Lelli L., Tricoli M., Sbarbati del Guerra R., Cascone M.G., et al. Poly(ester-ether-ester) block copolymers as biomaterials. J. Mater. Sci. Mater. Med. 1994, 5:33-39.
39. Chandrasekaran S.K., Capozza R., Wong P.S.L. Therapeutic systems and controlled drug delivery. J. Membr. Sci. 1978, 3:271-286.
40. Chirila T.V., Constable I.J., Crawford G.J., Vijayasekaran S., Thompson D.E., Chen Y.C., et al. Poly(2-hydroxyethyl methacrylate) sponges as implant materials: in vivo and in vitro evaluation of cellular invasion. Biomaterials 1993, 14:26-38.
41. Choueka J., Charvet J.L., Koval K.J., Alexander H., James K.S., Hooper K.A., et al. Canine bone response to tyrosine-derived polycarbonates and poly(L-lactic acid). J. Biomed. Mater. Res. 1996, 31:35-41.
42. Colas A., Curtis J. Silicone biomaterials: history and chemistry. Biomaterials Science. An Introduction to Materials in Medicine 2004, 80-86. Academic Press, San Diego, CA. 2nd Ed. B.D. Ratner, A.S. Hoffman, F.J. Schoen, J.E. Lemons (Eds.).
43. Cruise G.M., Hegre O.D., Lamberti F.V., Hager S.R., Hill R., Scharp D.S., et al. In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes. Cell Transplant. 1999, 8:293-306.
44. Curtis J., Colas A. Medical applications of silicones. Biomaterials Science. An Introduction to Materials in Medicine 2004, 697-707. Academic Press, San Diego, CA. 2nd Ed. B.D. Ratner, A.S. Hoffman, F.J. Schoen, J.E. Lemons (Eds.).
45. Cutright D.E., Beasley I.I.I., Perez B. Histologic comparison of polylactic and polyglycolic acid sutures. Oral Surg. Oral Med. Oral Pathol. 1971, 32:165-173.
46. Davis K.A., Anseth K.S. Controlled release from crosslinked degradable networks. Crit. Rev. Ther. Drug Carrier Syst. 2002, 19:385-423.
47. Davis K.A., Burdick J.A., Anseth K.S. Photoinitiated crosslinked degradable copolymer networks for tissue engineering applications. Biomaterials 2003, 24:2485-2495.
48. Deforest C.A., Polizzotti B.D., Anseth K.S. Sequential click reactions for synthesizing and patterning three-dimensional cell microenvironments. Nat. Mater. 2009, 8:659-664.
49. Domb A.J., Laurencin C.T., Israeli O., Gerhart T.N., Langer R. Formation of propylene fumarate oligomers for use in bioerodible bone cement composites. J. Polym. Sci. A 1990, 28:973-985.
50. Drotleff S., Lungwitz U., Breunig M., Dennis A., Blunk T., Tessmar J., et al. Biomimetic polymers in pharmaceutical and biomedical sciences. Eur. J. Pharm. Biopharm. 2004, 58:385-407.
51. Elisseeff J., Anseth K., Sims D., McIntosh W., Randolph M., Langer R. Transdermal photopolymerization for minimally invasive implantation. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:3104-3107.
52. Engelberg I., Kohn J. Physico-mechanical properties of degradable polymers used in medical applications: a comparative study. Biomaterials 1991, 12:292-304.
53. Falco E.E., Roth J.S., Fisher J.P. EH Networks as a scaffold for skeletal muscle regeneration in abdominal wall hernia repair. J. Surg. Res. 2007, 149:76-83.
54. Falco E.E., Patel M., Fisher J.P. Recent developments in cyclic acetal biomaterials for tissue engineering applications. Pharm. Res. 2008, 25:2348-2356.
55. Fisher J.P., Holland T.A., Dean D., Engel P.S., Mikos A.G. Synthesis and properties of photocross-linked poly(propylene fumarate) scaffolds. J. Biomater. Sci. Polym. Ed. 2001, 12:673-687.
56. Fisher J.P., Dean D., Mikos A.G. Photocrosslinking characteristics and mechanical properties of diethyl fumarate/poly(propylene fumarate) biomaterials. Biomaterials 2002, 23:4333-4343.
57. Fisher J.P., Vehof J.W.M., Dean D., van der Waerden J.P., Holland T.A., Mikos A.G., et al. Soft and hard tissue response to photocrosslinked poly(propylene fumarate) scaffolds in a rabbit model. J. Biomed. Mater. Res. 2002, 59:547-556.
58. Fisher J.P., Jo S., Mikos A.G., Reddi A.H. Thermoreversible hydrogel scaffolds for articular cartilage engineering. J. Biomed. Mater. Res. A 2004, 71:268-274.
59. Frazier D.D., Lathi V.K., Gerhart T.N., Hayes W.C. Ex vivo degradation of a poly(propylene glycol-fumarate) biodegradable particulate composite bone cement. J. Biomed. Mater. Res. 1997, 35:383-389.
60. Freed L.E., Vunjak N.G., Biron R.J., Eagles D.B., Lesnoy D.C., Barlow S.K., et al. Biodegradable polymer scaffolds for tissue engineering. Biotechnology (NY) 1994, 12:689-693.
61. Freed L.E., Langer R., Martin I., Pellis N.R., Vunjak-Novakovic G. Tissue engineering of cartilage in space. Proc. Natl. Acad. Sci. USA 1997, 94:13885-13890.
62. Fromstein J.D., Woodhouse K.A. Polyurethane biomaterials. Encyclopedia of Biomaterials and Biomedical Engineering 2006, 2304. Marcel Dekker, New York. 2nd. Ed. G.E. Wnek, G.L. Bowlin (Eds.).
63. Galler K.M., Cavender A., Yuwono V., Dong H., Shi S., Schmalz G., et al. Self-assembling peptide amphiphile nanofibers as a scaffold for dental stem cells. Tissue Eng. A 2008, 14:2051-2058.
64. Ganta S.R., Piesco N.P., Long P., Gassner R., Motta L.F., Papworth G.D., et al. Vascularization and tissue infiltration of a biodegradable polyurethane matrix. J. Biomed. Mater. Res. A 2003, 64:242-248.
65. Gilding D.K., Reed A.M. Biodegradable polymers for use in surgery - polyglycolic/poly(actic acid) homo- and copolymers: 1. Polymer 1979, 20:1459-1464.
66. Gogolewski S. Selected topics in biomedical polyurethanes. A review. Colloid Polym. Sci. 1989, 267:757-785.
67. Goldberg M., Mahon K., Anderson D. Combinatorial and rational approaches to polymer synthesis for medicine. Adv. Drug Deliv. Rev. 2008, 60:971-978.
68. Gonzalez A.L., Gobin A.S., West J.L., McIntire L.V., Smith C.W. Integrin interactions with immobilized peptides in polyethylene glycol diacrylate hydrogels. Tissue Eng. 2004, 10:1775-1786.
69. Göpferich A. Polymer degradation and erosion. Mechanisms and applications. Eur. J. Pharm. Biopharm. 1996, 42:1-11.
70. Göpferich A., Tessmar J. Polyanhydride degradation and erosion. Adv. Drug Deliv. Rev. 2002, 54:911-931.
71. Gref R., Minamitake Y., Peracchia M.T., Trubetskoy V., Torchilin V., Langer R. Biodegradable long-circulating polymeric nanospheres. Science 1994, 263:1600-1603.
72. Gref R., Minamitake Y., Peracchia M.T., Domb A., Trubetskoy V., Torchilin V., et al. Poly(ethylene glycol)-coated nanospheres: potential carriers for intravenous drug administration. Pharm. Biotechnol. 1997, 10:167-198.
73. Gref R., Luck M., Quellec P., Marchand M., Dellacherie E., Harnisch S., et al. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf. B 2000, 18:301-313.
74. Gresser J.D., Hsu S.H., Nagaoka H., Lyons C.M., Nieratko D.P., Wise D.L., et al. Analysis of a vinyl pyrrolidone/poly(propylene fumarate) resorbable bone cement. J. Biomed. Mater. Res. 1995, 29:1241-1247.
75. Gunatillake P.A., Adhikari R. Biodegradable synthetic polymers for tissue engineering. Eur. Cell. Mater. 2003, 5:1-16.
76. Gunatillake P.A., Martin D.J., Meijs G.F., McCarthy S.J., Adhikari R. Designing biostable polyurethane elastomers for biomedical implants. Aust. J. Chem. 2003, 56:545-557.
77. Gupta A.P., Kumar V. New emerging trends in synthetic biodegradable polymers - Polylactide: A critique. Eur. Polym. J. 2007, 43:4053-4074.
78. Hacker M., Tessmar J., Neubauer M., Blaimer A., Blunk T., Gopferich A., et al. Towards biomimetic scaffolds: anhydrous scaffold fabrication from biodegradable amine-reactive diblock copolymers. Biomaterials 2003, 24:4459-4473.
79. Harris J.M., Chess R.B. Effect of pegylation on pharmaceuticals. Nat. Rev. Drug Discov. 2003, 2:214-221.
80. Hartgerink J.D., Beniash E., Stupp S.I. Self-assembly and mineralization of peptide-amphiphile nanofibers. Science 2001, 294:1684-1688.
81. Hasegawa M., Sudo A., Shikinami Y., Uchida A. Biological performance of a three-dimensional fabric as artificial cartilage in the repair of large osteochondral defects in rabbit. Biomaterials 1999, 20:1969-1975.
82. He S., Timmer M.D., Yaszemski M.J., Yasko A.W., Engel P.S., Mikos A.G. Synthesis of biodegradable poly(propylene fumarate) networks with poly(propylene fumarate)-diacrylate macromers as crosslinking agents and characterization of their degradation products. Polymer 2001, 42:1251-1260.
83. Heller J. Biodegradable polymers in controlled drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 1984, 1:39-90.
84. Heller J., Barr J., Ng S.Y., Abdellauoi K.S., Gurny R. Poly(ortho esters): synthesis, characterization, properties and uses. Adv. Drug Deliv. Rev. 2002, 54:1015-1039.
85. Hench L.L. Biomaterials. Science 1980, 208:826-831.
86. Hench L.L., Polak J.M. Third-generation biomedical materials. Science 2002, 295:1014-1017.
87. Hendriks J.G.E., van Horn J.R., van der Mei H.C., Busscher H.J. Backgrounds of antibiotic-loaded bone cement and prosthesis-related infection. Biomaterials 2004, 25:545-556.
88. Hern D.L., Hubbell J.A. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing. J. Biomed. Mater. Res. 1998, 39:266-276.
89. Hoffman A.S. Hydrogels for biomedical applications. Adv. Drug Deliv. Rev. 2002, 54:3-12.
90. Holland T.A., Bodde E.W.H., Baggett L.S., Tabata Y., Mikos A.G., Jansen J.A. Osteochondral repair in the rabbit model utilizing bilayered, degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds. J. Biomed. Mater. Res. A 2005, 75:156-167.
91. Holland T.A., Tabata Y., Mikos A.G. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J. Control. Release 2005, 101:111-125.
92. Horch R.A., Shahid N., Mistry A.S., Timmer M.D., Mikos A.G., Barron A.R. Nanoreinforcement of poly(propylene fumarate)-based networks with surface modified alumoxane nanoparticles for bone tissue engineering. Biomacromolecules 2004, 5:1990-1998.
93. Hosseinkhani H., Hosseinkhani M., Tian F., Kobayashi H., Tabata Y. Osteogenic differentiation of mesenchymal stem cells in self-assembled peptide-amphiphile nanofibers. Biomaterials 2006, 27:4079-4086.
94. Hou Q.P., de Bank P.A., Shakesheff K.M. Injectable scaffolds for tissue regeneration. J. Mater. Chem. 2004, 14:1915-1923.
95. Houchin M.L., Topp E.M. Chemical degradation of peptides and proteins in PLGA: a review of reactions and mechanisms. J. Pharm. Sci. 2008, 97:2395-2404.
96. Howard G.T. Biodegradation of polyurethane: a review. Int. Biodeterior. Biodegradation 2002, 49:245-252.
97. Hubbell J.A. Biomaterials in tissue engineering. Biotechnology (NY) 1995, 13:565-576.
98. Hubbell J.A. Synthetic biodegradable polymers for tissue engineering and drug delivery. Curr. Opin. Solid State Mater. Sci. 1998, 3:246-251.
99. Hutmacher D.W. Scaffolds in tissue engineering bone and cartilage. Biomaterials 2000, 21:2529-2543.
100. Ibim S.E.M., Uhrich K.E., Attawia M., Shastri V.R., El-Amin S.F., Bronson R., et al. Preliminary in vivo report on the osteocompatibility of poly(anhydride- co-imides) evaluated in a tibial model. J. Biomed. Mater. Res. 1998, 43:374-379.
101. Ibusuki S., Fujii Y., Iwamoto Y., Matsuda T. Tissue-engineered cartilage using an injectable and in situ gelable thermoresponsive gelatin: fabrication and in vitro performance. Tissue Eng. 2003, 9:371-384.
102. Ibusuki S., Iwamoto Y., Matsuda T. System-engineered cartilage using poly(N-isopropylacrylamide)-grafted gelatin as in situ-formable scaffold: in vivo performance. Tissue Eng. 2003, 9:1133-1142.
103. Jacobs J.J., Sumner D.R., Galante J.O. Mechanisms of bone loss associated with total hip replacement. Orthop. Clin. North Am. 1993, 24:583-590.
104. Jain R.A. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000, 21:2475-2490.
105. Jeong B., Bae Y.H., Lee D.S., Kim S.W. Biodegradable block copolymers as injectable drug-delivery systems. Nature 1997, 388:860-862.
106. Jeong B., Kim S.W., Bae Y.H. Thermosensitive sol-gel reversible hydrogels. Adv. Drug Deliv. Rev. 2002, 54:37-51.
107. Jo S., Shin H., Shung A.K., Fisher J.P., Mikos A.G. Synthesis and characterization of oligo(poly(ethylene glycol) fumarate) macromer. Macromolecules 2001, 34:2839-2844.
108. Juni K., Nakano M. Poly(hydroxy acids) in drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 1987, 3:209-232.
109. Kaihara S., Matsumura S., Fisher J.P. Synthesis and properties of poly [poly (ethylene glycol)-co-cyclic acetal] based hydrogels. Macromolecules 2007, 40:7625-7632.
110. Kaihara S., Matsumura S., Fisher J.P. Synthesis and characterization of cyclic acetal based degradable hydrogels. Eur. J. Pharm. Biopharm. 2008, 68:67-73.
111. Kasper F.K., Kushibiki T., Kimura Y., Mikos A.G., Tabata Y. In vivo release of plasmid DNA from composites of oligo(poly(ethylene glycol)fumarate) and cationized gelatin microspheres. J. Control. Release 2005, 107:547-561.
112. Kasper F.K., Tanahashi K., Fisher J.P., Mikos A.G. Synthesis of poly(propylene fumarate). Nat. Protoc. 2009, 4:518-525.
113. Katti D.S., Lakshmi S., Langer R., Laurencin C.T. Toxicity, biodegradation and elimination of polyanhydrides. Adv. Drug Deliv. Rev. 2002, 54:933-961.
114. Kenny S.M., Buggy M. Bone cements and fillers: a review. J. Mater. Sci. Mater. Med. 2003, 14:923-938.
115. Kissel T., Li Y., Unger F. ABA-triblock copolymers from biodegradable polyester A-blocks and hydrophilic poly(ethylene oxide) B-blocks as a candidate for in situ forming hydrogel delivery systems for proteins. Adv. Drug Deliv. Rev. 2002, 54:99-134.
116. Kohn J., Langer R. Poly(iminocarbonates) as potential biomaterials. Biomaterials 1986, 7:176-182.
117. Król P. Synthesis methods, chemical structures and phase structures of linear polyurethanes. Properties and applications of linear polyurethanes in polyurethane elastomers, copolymers and ionomers. Prog. Mater. Sci. 2007, 52:915-1015.
118. Kumar N., Langer R.S., Domb A.J. Polyanhydrides: an overview. Adv. Drug Deliv. Rev. 2002, 54:889-910.
119. Langer R. New methods of drug delivery. Science 1990, 249:1527-1533.
120. Langer R.S., Peppas N.A. Present and future applications of biomaterials in controlled drug delivery systems. Biomaterials 1981, 2:201-214.
121. Langer R., Vacanti J.P. Tissue engineering. Science 1993, 260:920-926.
122. Langer R., Brem H., Tapper D. Biocompatibility of polymeric delivery systems for macromolecules. J. Biomed. Mater. Res. 1981, 15:267-277.
123. Langone F., Lora S., Veronese F.M., Caliceti P., Parnigotto P.P., Valenti F., et al. Peripheral nerve repair using a poly(organo)phosphazene tubular prosthesis. Biomaterials 1995, 16:347-353.
124. Laurencin C.T., El-Amin S.F., Ibim S.E., Willoughby D.A., Attawia M., Allcock H.R., et al. A highly porous three-dimensional polyphosphazene polymer matrix for skeletal tissue regeneration. J. Biomed. Mater. Res. 1996, 30:133-138.
125. Lee J.W., Hua F.J., Lee D.S. Thermoreversible gelation of biodegradable poly(É-caprolactone) and poly(ethylene glycol) multiblock copolymers in aqueous solutions. J. Control. Release 2001, 73:315-327.
126. Lee S.B. A new class of biodegradable thermosensitive polymers. 2. hydrolytic properties and salt effect on the lower critical solution temperature of poly(organophosphazenes) with methoxypoly(ethylene glycol) and amino acid esters as side groups. Macromolecules 1999, 32:7820-7827.
127. Leong K.W., Simonte V., Langer R. Synthesis of polyanhydrides: melt-polycondensation, dehydrochlorination, and dehydrative coupling. Macromolecules 1987, 20:705-712.
128. Lewin S.L., Miller T.A. A review of epidemiologic studies analyzing the relationship between breast implants and connective tissue diseases. Plast. Reconstr. Surg. 1997, 100:1309-1313.
129. Li S. Hydrolytic degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids. J. Biomed. Mater. Res. 1999, 48:342-353.
130. Lieb E., Tessmar J., Hacker M., Fischbach C., Rose D., Blunk T., et al. Poly(D, L-lactic acid)-poly(ethylene glycol)-monomethyl ether diblock copolymers control adhesion and osteoblastic differentiation of marrow stromal cells. Tissue Eng. 2003, 9:71-84.
131. Lin H.B., Sun W., Mosher D.F., Garcia-Echeverria C., Schaufelberger K., Lelkes P.I., Cooper S.L. Synthesis, surface, and cell-adhesion properties of polyurethanes containing covalently grafted RGD-peptides. J. Biomed. Mater. Res. 1994, 28:329-342.
132. Liu S.Q., Tay R., Khan M., Rachel Ee P.L., Hedrick J.L., Yang Y.Y. Synthetic hydrogels for controlled stem cell differentiation. Soft Matter 2009, 6:67-81.
133. Lloyd A.W., Faragher R.G.A., Denyer S.P. Ocular biomaterials and implants. Biomaterials 2001, 22:769-785.
134. Lu S., Anseth K.S. Photopolymerization of multilaminated poly(HEMA) hydrogels for controlled release. J. Control. Release 1999, 57:291-300.
135. Lucke A., Kiermaier J., Gopferich A. Peptide acylation by poly(α-hydroxy esters). Pharm. Res. 2002, 19:175-181.
136. Lutolf M.P., Hubbell J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. 2005, 23:47-55.
137. Lutolf M.P., Lauer-Fields J.L., Schmoekel H.G., Metters A.T., Weber F.E., Fields G.B., et al. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:5413-5418.
138. Lutolf M.P., Weber F.E., Schmoekel H.G., Schense J.C., Kohler T., Muller R., et al. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat. Biotechnol. 2003, 21:513-518.
139. Lutz J.F., Börner H.G. Modern trends in polymer bioconjugates design. Progr. Polymer Sci. 2008, 33:1-39.
140. Mack E.J., Okano T., Kim S.W. Biomedical applications of poly(2-hydroxyethyl methacrylate) and its copolymers. Hydrogels in Medicine and Pharmacy 1987, Vol. II:65-93. CRC Press, Boca Raton, FL, USA. N.A. Peppas (Ed.).
141. Matsuda T., Nagase J., Ghoda A., Hirano Y., Kidoaki S., Nakayama Y. Phosphorylcholine-endcapped oligomer and block co-oligomer and surface biological reactivity. Biomaterials 2003, 24:4517-4527.
142. Meyer D.E., Chilkoti A. Purification of recombinant proteins by fusion with thermally-responsive polypeptides. Nat. Biotechnol. 1999, 17:1112-1115.
143. Middleton J.C., Tipton A.J. Synthetic biodegradable polymers as orthopedic devices. Biomaterials 2000, 21:2335-2346.
144. Miller R.A., Brady J.M., Cutright D.E. Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios. J. Biomed. Mater. Res. 1977, 11:711-719.
145. Mistry A.S., Mikos A.G., Jansen J.A. Degradation and biocompatibility of a poly(propylene fumarate)-based/alumoxane nanocomposite for bone tissue engineering. J. Biomed. Mater. Res. A 2007, 83:940-953.
146. Mistry A.S., Cheng S.H., Yeh T., Christenson E., Jansen J.A., Mikos A.G. Fabrication and in vitro degradation of porous fumarate-based polymer/alumoxane nanocomposite scaffolds for bone tissue engineering. J. Biomed. Mater. Res. A 2009, 89:68-79.
147. Mistry A.S., Pham Q.P., Schouten C., Yeh T., Christenson E.M., Mikos A.G., et al. In vivo bone biocompatibility and degradation of porous fumarate-based polymer/alumoxane nanocomposites for bone tissue engineering. J. Biomed. Mater. Res. A 2010, 92:451-462.
148. Mooney D.J., Mikos A.G. Growing new organs. Sci. Am. 1999, 280:60-65.
149. Morikawa N., Matsuda T. Thermoresponsive artificial extracellular matrix: N-isopropylacrylamide-graft-copolymerized gelatin. J. Biomater. Sci. Polym. Ed 2002, 13:167-183.
150. Mosbach K., Ramstrom O. The emerging technique of molecular imprinting and its future impact on biotechnology. Nat. Biotechnol. 1996, 14:163-170.
151. Motlagh D., Allen J., Hoshi R., Yang J., Lui K., Ameer G. Hemocompatibility evaluation of poly(diol citrate) in vitro for vascular tissue engineering. J. Biomed. Mater. Res. A 2007, 82:907-916.
152. Muggli D.S., Burkoth A.K., Anseth K.S. Crosslinked polyanhydrides for use in orthopedic applications: degradation behavior and mechanics. J. Biomed. Mater. Res. 1999, 46:271-278.
153. Nerem R.M. Tissue engineering: the hope, the hype, and the future. Tissue Eng. 2006, 12:1143-1150.
154. Ng S.Y., Vandamme T., Taylor M.S., Heller J. Synthesis and erosion studies of self-catalyzed poly(ortho ester)s. Macromolecules 1997, 30:770-772.
155. Nguyen K.T., West J.L. Photopolymerizable hydrogels for tissue engineering applications. Biomaterials 2002, 23:4307-4314.
156. Ohya S., Nakayama Y., Matsuda T. Thermoresponsive artificial extracellular matrix for tissue engineering: hyaluronic acid bioconjugated with poly(N-isopropylacrylamide) grafts. Biomacromolecules 2001, 2:856-863.
157. Panyam J., Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 2003, 55:329-347.
158. Park H., Temenoff J.S., Holland T.A., Tabata Y., Mikos A.G. Delivery of TGFβ1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications. Biomaterials 2005, 26:7095-7103.
159. Patterson J., Martino M.M., Hubbell J.A. Biomimetic materials in tissue engineering. Mater. Today 2010, 13:14-22.
160. Peppas N.A., Keys K.B., Torres-Lugo M., Lowman A.M. Poly(ethylene glycol)-containing hydrogels in drug delivery. J. Control. Release 1999, 62:81-87.
161. Peppas N.A., Bures P., Leobandung W., Ichikawa H. Hydrogels in pharmaceutical formulations. Eur. J. Pharm. Biopharm. 2000, 50:27-46.
162. Peter S.J., Miller M.J., Yaszemski M.J., Mikos A.G. Poly(propylene fumarate). Handbook of Biodegradable Polymers 1997, 87-97. Harwood Academic, Amsterdam. A.J. Domb, J. Kost, D.M. Wiseman (Eds.).
163. Peter S.J., Nolley J.A., Widmer M.S., Merwin J.E., Yaszemski M.J., Yasko A.W., et al. In vitro degradation of a poly(propylene fumarate)/β-tricalcium phosphate composite orthopaedic scaffold. Tissue Eng. 1997, 3:207-215.
164. Peter S.J., Miller M.J., Yasko A.W., Yaszemski M.J., Mikos A.G. Polymer concepts in tissue engineering. J. Biomed. Mater. Res. 1998, 43:422-427.
165. Peter S.J., Miller S.T., Zhu G., Yasko A.W., Mikos A.G. In vivo degradation of a poly(propylene fumarate)/β-tricalcium phosphate injectable composite scaffold. J. Biomed. Mater. Res. 1998, 41:1-7.
166. Peter S.J., Kim P., Yasko A.W., Yaszemski M.J., Mikos A.G. Crosslinking characteristics of an injectable poly(propylene fumarate)/β-tricalcium phosphate paste and mechanical properties of the crosslinked composite for use as a biodegradable bone cement. J. Biomed. Mater. Res. 1999, 44:314-321.
167. Peter S.J., Suggs L.J., Yaszemski M.J., Engel P.S., Mikos A.G. Synthesis of poly(propylene fumarate) by acylation of propylene glycol in the presence of a proton scavenger. J. Biomater. Sci. Polym. Ed. 1999, 10:363-373.
168. Peter S.J., Lu L., Kim D.J., Mikos A.G. Marrow stromal osteoblast function on a poly(propylene fumarate)/β-tricalcium phosphate biodegradable orthopaedic composite. Biomaterials 2000, 21:1207-1213.
169. Petrova T., Manolova N., Rashkov I., Li S., Vert M. Synthesis and characterization of poly(oxyethylene)-poly(caprolactone) multiblock copolymers. Polym. Int. 1998, 45:419-426.
170. Pham Q.P., Sharma U., Mikos A.G. Electrospinning of polymeric nanofibers for tissue engineering applications: a review. Tissue Eng. 2006, 12:1197-1211.
171. Photos P.J., Bacakova L., Discher B., Bates F.S., Discher D.E. Polymer vesicles in vivo: correlations with PEG molecular weight. J. Control. Release 2003, 90:323-334.
172. Pitt C.G., Jeffcoat A.R., Zweidinger R.A., Schindler A. Sustained drug delivery systems. I. The permeability of poly(É-caprolactone), poly(DL-lactic acid), and their copolymers. J. Biomed. Mater. Res. 1979, 13:497-507.
173. Pitt G.G., Gratzl M.M., Kimmel G.L., Surles J., Sohindler A. Aliphatic polyesters II. The degradation of poly (DL-lactide), poly (É-caprolactone), and their copolymers in vivo. Biomaterials 1981, 2:215-220.
174. Pulapura S., Kohn J. Tyrosine-derived polycarbonates: backbone-modified 'pseudo'-poly(amino acids) designed for biomedical applications. Biopolymers 1992, 32:411-417.
175. Ratner B.D. A history of biomaterials. Biomaterials Science. An Introduction to Materials in Medicine 2004, 10-19. Academic Press, San Diego, CA. 2nd Ed. B.D. Ratner, A.S. Hoffman, F.J. Schoen, J.E. Lemons (Eds.).
176. Reed A.M., Gilding D.K. Biodegradable polymers for use in surgery - poly(glycolic)/poly(lactic acid) homo and copolymers: 2. In vitro degradation. Polymer 1981, 22:494-498.
177. Reimschuessel H.K. General aspects in polymer synthesis. Environ. Health Perspect. 1975, 11:9-20.
178. Roberts M.J., Bentley M.D., Harris J.M. Chemistry for peptide and protein PEGylation. Adv. Drug Deliv. Rev. 2002, 54:459-476.
179. Rodriguez F.J., Gomez N., Perego G., Navarro X. Highly permeable polylactide-caprolactone nerve guides enhance peripheral nerve regeneration through long gaps. Biomaterials 1999, 20:1489-1500.
180. Ruel-Gariepy E., Leroux J.C. In situ-forming hydrogels - review of temperature-sensitive systems. Eur. J. Pharm. Biopharm. 2004, 58:409-426.
181. Saad B., Hirt T.D., Welti M., Uhlschmid G.K., Neuenschwander P., Suter U.W. Development of degradable polyesterurethanes for medical applications: in vitro and in vivo evaluations. J. Biomed. Mater. Res. 1997, 36:65-74.
182. Saha S., Pal S. Mechanical properties of bone cement: a review. J. Biomed. Mater. Res. 1984, 18:435-462.
183. Salgado A.J., Coutinho O.P., Reis R.L. Bone tissue engineering: state of the art and future trends. Macromol. Biosci. 2004, 4:743-765.
184. Saltzman W.M., Olbricht W.L. Building drug delivery into tissue engineering. Nat. Rev. Drug Discov. 2002, 1:177-186.
185. Sanchez-Guerrero J., Colditz G.A., Karlson E.W., Hunter D.J., Speizer F.E., Liang M.H. Silicone breast implants and the risk of connective-tissue diseases and symptoms. N. Engl. J. Med. 1995, 332:1666-1670.
186. Santerre J.P., Woodhouse K., Laroche G., Labow R.S. Understanding the biodegradation of polyurethanes: from classical implants to tissue engineering materials. Biomaterials 2005, 26:7457-7470.
187. Sawhney A.S., Hubbell J.A. Rapidly degraded terpolymers of dl-lactide, glycolide, and epsilon-caprolactone with increased hydrophilicity by copolymerization with polyethers. J. Biomed. Mater. Res. 1990, 24:1397-1411.
188. Schacht E., Vandorpe J., Dejardin S., Lemmouchi Y., Seymour L. Biomedical applications of degradable polyphosphazenes. Biotechnol. Bioeng. 1996, 52:102-108.
189. Schild H.G. Poly(N-isopropylacrylamide): experiment, theory and application. Progr. Polymer Sci. 1992, 17:163-249.
190. Schild H.G., Tirrell D.A. Microcalorimetric detection of lower critical solution temperatures in aqueous polymer solutions. J. Phys. Chem. 1990, 94:4352-4356.
191. Schmeltzer R.C., Uhrich K.E. Synthesis and characterization of antiseptic-based poly(anhydride-esters). Polymer Bull. 2006, 57:281-291.
192. Seal B.L., Otero T.C., Panitch A. Polymeric biomaterials for tissue and organ regeneration. Mat. Sci. Eng. R 2001, 34:147-230.
193. Segura T., Shea L.D. Surface-tethered DNA complexes for enhanced gene delivery. Bioconjug. Chem. 2002, 13:621-629.
194. Shi X., Hudson J.L., Spicer P.P., Tour J.M., Krishnamoorti R., Mikos A.G. Rheological behaviour and mechanical characterization of injectable poly(propylene fumarate)/single-walled carbon nanotube composites for bone tissue engineering. Nanotechnology 2005, 16:S531-S538.
195. Shi X., Sitharaman B., Pham Q.P., Liang F., Wu K., Edward Billups W., et al. Fabrication of porous ultra-short single-walled carbon nanotube nanocomposite scaffolds for bone tissue engineering. Biomaterials 2007, 28:4078-4090.
196. Shi X., Sitharaman B., Pham Q.P., Spicer P.P., Hudson J.L., Wilson L.J., et al. In vitro cytotoxicity of single-walled carbon nanotube/biodegradable polymer nanocomposites. J. Biomed. Mater. Res. A 2008, 86:813-823.
197. Shin H., Jo S., Mikos A.G. Modulation of marrow stromal osteoblast adhesion on biomimetic oligo[poly(ethylene glycol) fumarate] hydrogels modified with Arg-Gly-Asp peptides and a poly(ethyleneglycol) spacer. J. Biomed. Mater. Res. 2002, 61:169-179.
198. Shin H., Temenoff J.S., Mikos A.G. In vitro cytotoxicity of unsaturated oligo[poly(ethylene glycol)fumarate] macromers and their cross-linked hydrogels. Biomacromolecules 2003, 4:552-560.
199. Shin H., Jo S., Mikos A.G. Biomimetic materials for tissue engineering. Biomaterials 2003, 24:4353-4364.
200. Shin H., Quinten Ruhe P., Mikos A.G., Jansen J.A. In vivo bone and soft tissue response to injectable, biodegradable oligo(poly(ethylene glycol) fumarate) hydrogels. Biomaterials 2003, 24:3201-3211.
201. Shung A.K., Behravesh E., Jo S., Mikos A.G. Crosslinking characteristics of and cell adhesion to an injectable poly(propylene fumarate-co-ethylene glycol) hydrogel using a water-soluble crosslinking system. Tissue Eng. 2003, 9:243-254.
202. Silverman B.G., Brown S.L., Bright R.A., Kaczmarek R.G., Arrowsmith-Lowe J.B., Kessler D.A. Reported complications of silicone gel breast implants: an epidemiologic review. Ann. Intern. Med. 1996, 124:744-756.
203. Simon J.A., Ricci J.L., di Cesare P.E. Bioresorbable fracture fixation in orthopedics: a comprehensive review. Part II. Clinical studies. Am. J. Orthop. 1997, 26:754-762.
204. Sinha V.R., Bansal K., Kaushik R., Kumria R., Trehan A. Poly-[epsilon]-caprolactone microspheres and nanospheres: an overview. Int. J. Pharm. 2004, 278:1-23.
205. Sitharaman B., Shi X., Walboomers X.F., Liao H., Cuijpers V., Wilson L.J., et al. In vivo biocompatibility of ultra-short single-walled carbon nanotube/biodegradable polymer nanocomposites for bone tissue engineering. Bone 2008, 43:362-370.
206. Skarja G.A., Woodhouse K.A. In vitro degradation and erosion of degradable, segmented polyurethanes containing an amino acid-based chain extender. J. Biomater. Sci. Polym. Ed. 2001, 12:851-873.
207. Soga K., Shiono T. Ziegler-Natta catalysts for olefin polymerizations. Progr. Polymer Sci. 1997, 22:1503-1546.
208. Solheim E., Sudmann B., Bang G., Sudmann E. Biocompatibility and effect on osteogenesis of poly(ortho ester) compared to poly(DL-lactic acid). J. Biomed. Mater. Res. 2000, 49:257-263.
209. Song J., Saiz E., Bertozzi C.R. A new approach to mineralization of biocompatible hydrogel scaffolds: an efficient process toward 3-dimensional bonelike composites. J. Am. Chem. Soc. 2003, 125:1236-1243.
210. Stile R.A., Burghardt W.R., Healy K.E. Synthesis and characterization of injectable poly(N-isopropylacrylamide)-based hydrogels that support tissue formation in vitro. Macromolecules 1999, 32:7370-7379.
211. Stokes K., Mcvenes R., Anderson J.M. Polyurethane elastomer biostability. J. Biomater. Appl. 1995, 9:321-354.
212. Stupp S.I., LeBonheur V., Walker K., Li L.S., Huggins K.E., Keser M., et al. Supramolecular materials: self-organized nanostructures. Science 1997, 276:384-389.
213. Suggs L.J., Payne R.G., Yaszemski M.J., Alemany L.B., Mikos A.G. Synthesis and characterization of a block copolymer consisting of poly(propylene fumarate) and poly(ethylene glycol). Macromolecules 1997, 30:4318-4323.
214. Suggs L.J., Shive M.S., Garcia C.A., Anderson J.M., Mikos A.G. In vitro cytotoxicity and in vivo biocompatibility of poly(propylene fumarate-co-ethylene glycol) hydrogels. J. Biomed. Mater. Res. 1999, 46:22-32.
215. Suggs L.J., West J.L., Mikos A.G. Platelet adhesion on a bioresorbable poly(propylene fumarate-co-ethylene glycol) copolymer. Biomaterials 1999, 20:683-690.
216. Tabata Y. Tissue regeneration based on growth factor release. Tissue Eng. 2003, 9:S5-15.
217. Tanahashi K., Mikos A.G. Cell adhesion on poly(propylene fumarate-co-ethylene glycol) hydrogels. J. Biomed. Mater. Res. 2002, 62:558-566.
218. Tanahashi K., Mikos A.G. Protein adsorption and smooth muscle cell adhesion on biodegradable agmatine-modified poly(propylene fumarate-co-ethylene glycol) hydrogels. J. Biomed. Mater. Res. A 2003, 67:448-457.
219. Temenoff J.S., Mikos A.G. Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials 2000, 21:2405-2412.
220. Temenoff J.S., Athanasiou K.A., LeBaron R.G., Mikos A.G. Effect of poly(ethylene glycol) molecular weight on tensile and swelling properties of oligo(poly(ethylene glycol) fumarate) hydrogels for cartilage tissue engineering. J. Biomed. Mater. Res. 2002, 59:429-437.
221. Temenoff J.S., Park H., Jabbari E., Conway D.E., Sheffield T.L., Ambrose C.G., et al. Thermally cross-linked oligo(poly(ethylene glycol) fumarate) hydrogels support osteogenic differentiation of encapsulated marrow stromal cells in vitro. Biomacromolecules 2004, 5:5-10.
222. Temenoff J.S., Park H., Jabbari E., Sheffield T.L., LeBaron R.G., Ambrose C.G., et al. In vitro osteogenic differentiation of marrow stromal cells encapsulated in biodegradable hydrogels. J. Biomed. Mater. Res. A 2004, 70:235-244.
223. Tessmar J., Mikos A., Gopferich A. The use of poly(ethylene glycol)-block-poly(lactic acid) derived copolymers for the rapid creation of biomimetic surfaces. Biomaterials 2003, 24:4475-4486.
224. Timmer M.D., Ambrose C.G., Mikos A.G. Evaluation of thermal- and photo-crosslinked biodegradable poly(propylene fumarate)-based networks. J. Biomed. Mater. Res. A 2003, 66:811-818.
225. Tunc Y., Hasirci N., Yesilada A., Ulubayram K. Comonomer effects on binding performances and morphology of acrylate-based imprinted polymers. Polymer 2006, 47:6931-6940.
226. US Food and Drug Administration (FDA) (2004). FDA Breast Implant Consumer Handbook 2004. Center for Devices and Radiological Health. Available online: . http://www.fda.gov/cdrh/breastimplants/indexbip.html.
227. Uhrich K.E., Gupta A., Thomas T.T., Laurencin C.T., Langer R. Synthesis and characterization of degradable poly(anhydride-co-imides). Macromolecules 1995, 28:2184-2193.
228. Uhrich K.E., Cannizzaro S.M., Langer R.S., Shakesheff K.M. Polymeric systems for controlled drug release. Chem. Rev. 1999, 99:3181-3198.
229. Ulbricht M. Advanced functional polymer membranes. Polymer 2006, 47:2217-2262.
230. van Dijk M., Rijkers D.T.S., Liskamp R.M.J., van Nostrum C.F., Hennink W.E. Synthesis and applications of biomedical and pharmaceutical polymers via click chemistry methodologies. Bioconjug. Chem. 2009, 20:2001-2016.
231. Varghese S., Elisseeff J. Hydrogels for musculoskeletal tissue engineering. Adv. Polym. Sci. 2006, 203:95-144.
232. Vonarbourg A., Passirani C., Saulnier P., Benoit J.P. Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials 2006, 27:4356-4373.
233. Wang H., Dong J.H., Qiu K.Y., Gu Z.W. Synthesis of poly(1,4-dioxan-2-one-co-trimethylene carbonate) for application in drug delivery systems. J. Polym. Sci. A 1998, 36:1301-1307.
234. Webb A.R., Yang J., Ameer G.A. Biodegradable polyester elastomers in tissue engineering. Expert Opin. Biol. Ther. 2004, 4:801-812.
235. Webber M.J., Kessler J.A., Stupp S.I. Emerging peptide nanomedicine to regenerate tissues and organs. J. Intern. Med. 2010, 267:71-88.
236. Westphal M., Hilt D.C., Bortey E., Delavault P., Olivares R., Warnke P.C., et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro-Oncology 2003, 5:79-88.
237. Wichterle O., Lim D. Hydrophilic gels for biological use. Nature 1960, 185:117-118.
238. Xia Z., Triffitt J.T. A review on macrophage responses to biomaterials. Biomed. Mater. 2006, 1:R1-R9.
239. Xue L., Greisler H.P. Biomaterials in the development and future of vascular grafts. J. Vasc. Surg. 2003, 37:472-480.
240. Yang J., Webb A.R., Ameer G.A. Novel citric acid-based biodegradable elastomers for tissue engineering. Adv. Mater. 2004, 16:511-516.
241. Yang J., Webb A.R., Pickerill S.J., Hageman G., Ameer G.A. Synthesis and evaluation of poly(diol citrate) biodegradable elastomers. Biomaterials 2006, 27:1889-1898.
242. Yang K.K., Li X.L., Wang Y.Z. Poly(p-dioxanone) and its copolymers. J. Macromol. Sci. Poly. Rev. 2002, 42:373-398.
243. Yaszemski M.J., Payne R.G., Hayes W.C., Langer R., Mikos A.G. In vitro degradation of a poly(propylene fumarate)-based composite material. Biomaterials 1996, 17:2127-2130.
244. Yoshimoto H., Shin Y.M., Terai H., Vacanti J.P. A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials 2003, 24:2077-2082.
245. Young C.D., Wu J.R., Tsou T.L. Fabrication and characteristics of polyHEMA artificial skin with improved tensile properties. J. Membr. Sci. 1998, 146:83-93.
246. Zhang J., Doll B.A., Beckman E.J., Hollinger J.O. A biodegradable polyurethane-ascorbic acid scaffold for bone tissue engineering. J. Biomed. Mater. Res. A 2003, 67:389-400.
247. Zhao H., Ameer G.A. Modulating the mechanical properties of poly(diol citrates) via the incorporation of a second type of crosslink network. J. Appl. Polym. Sci. 2009, 114:1464-1470.